Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo Renal Transplant Recipient.”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03507829
What this trial is testing

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

Who this might be right for
Hyperglycemia
Medical University of Vienna 263
Testing effectiveness (Phase 2)Study completedNCT00492869
What this trial is testing

Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 124
Post-approval studies (Phase 4)Study completedNCT02084446
What this trial is testing

Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant

Who this might be right for
Transplantation InfectionCytomegalovirus Infections
Ronaldo de Matos Esmeraldo, MD 120
Large-scale testing (Phase 3)Study completedNCT01025817
What this trial is testing

Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Novartis Pharmaceuticals 613
Large-scale testing (Phase 3)Study completedNCT00064701
What this trial is testing

Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 668
Large-scale testing (Phase 3)Study completedNCT00248313
What this trial is testing

Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus

Who this might be right for
Kidney Disease
Wyeth is now a wholly owned subsidiary of Pfizer 470
Not applicableStudy completedNCT01496417
What this trial is testing

Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores

Who this might be right for
End-Stage Renal Disease
University of Maryland 20
Large-scale testing (Phase 3)UnknownNCT02314312
What this trial is testing

Efficacy and Safety of Everolimus in de Novo Kidney Transplant Recipients of ECD or AKI Donors

Who this might be right for
Transplantation of KidneyExpanded Criteria DonorECD
Mahidol University 48
Not applicableUnknownNCT06013358
What this trial is testing

DdcfDNA in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Seoul National University Hospital 200
Large-scale testing (Phase 3)Study completedNCT00239031
What this trial is testing

Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids

Who this might be right for
Denovo Renal Transplantation
Novartis 117
Not applicableStudy completedNCT01265537
What this trial is testing

A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf

Who this might be right for
Acute Graft RejectionDiabetes
University of British Columbia 30
Large-scale testing (Phase 3)Ended earlyNCT01442337
What this trial is testing

Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 21
Post-approval studies (Phase 4)Study completedNCT00537862
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion Based Regimen in de Novo Living Donor Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Novartis Pharmaceuticals 200
Post-approval studies (Phase 4)UnknownNCT01744470
What this trial is testing

Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)

Who this might be right for
De Novo Transplant Disease
University Hospital, Tours 286
Large-scale testing (Phase 3)Study completedNCT00189202
What this trial is testing

Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans

Who this might be right for
End Stage Renal DiseaseKidney Transplantation
University of Michigan 49
Post-approval studies (Phase 4)Study completedNCT00371826
What this trial is testing

SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus

Who this might be right for
Renal Transplanted Recipients
Novartis Pharmaceuticals 126
Post-approval studies (Phase 4)Study completedNCT00195468
What this trial is testing

Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus

Who this might be right for
Kidney FailureGraft vs Host Disease
Wyeth is now a wholly owned subsidiary of Pfizer 280
Post-approval studies (Phase 4)Study completedNCT00312143
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

Who this might be right for
De Novo Kidney Transplant Recipients
Novartis 35
Large-scale testing (Phase 3)Study completedNCT00167947
What this trial is testing

Study Evaluating Sirolimus in Kidney Transplant Recipients.

Who this might be right for
Kidney FailureGraft vs Host Disease
Wyeth is now a wholly owned subsidiary of Pfizer 150
Post-approval studies (Phase 4)UnknownNCT02311010
What this trial is testing

Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic Polymorphism

Who this might be right for
Kidney Diseases
Université Catholique de Louvain 150
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation